Pliant Therapeutics Inc (PLRX)
13.98
+0.73
(+5.51%)
USD |
NASDAQ |
May 03, 16:00
14.25
+0.27
(+1.93%)
After-Hours: 20:00
Pliant Therapeutics Shareholders Equity (Quarterly): 473.58M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 473.58M |
| September 30, 2023 | 503.05M |
| June 30, 2023 | 533.06M |
| March 31, 2023 | 561.92M |
| December 31, 2022 | 313.34M |
| September 30, 2022 | 336.99M |
| June 30, 2022 | 147.79M |
| March 31, 2022 | 173.79M |
| December 31, 2021 | 199.06M |
| Date | Value |
|---|---|
| September 30, 2021 | 220.44M |
| June 30, 2021 | 243.98M |
| March 31, 2021 | 264.17M |
| December 31, 2020 | 283.06M |
| September 30, 2020 | 300.35M |
| June 30, 2020 | 315.82M |
| March 31, 2020 | 173.56M |
| December 31, 2019 | -0.435M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.435M
Minimum
Dec 2019
561.92M
Maximum
Mar 2023
296.68M
Average
283.06M
Median
Dec 2020
Shareholders Equity (Quarterly) Benchmarks
| Masimo Corp | 1.365B |
| Liquidia Corp | 47.29M |
| Vor Biopharma Inc | 150.72M |
| CEL-SCI Corp | 12.65M |
| AIM ImmunoTech Inc | 10.23M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 512.15M |
| Total Liabilities (Quarterly) | 38.58M |